HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tolerability and Safety of a Nutritional Supplement with Potential as Adjuvant in Colorectal Cancer Therapy: A Randomized Trial in Healthy Volunteers.

Abstract
Bioactive supplements display relevant therapeutic properties when properly applied according to validated molecular effects. Our previous research efforts established the basis to develop a dietary supplement based on a Rosmarinus officinalis supercritical extract. This was enriched in phenolic diterpenes (RE) with proven properties against signaling pathways involved in colon tumorigenesis, and shark liver oil rich in alkylglycerols (AKG) as a bioactive lipid vehicle to improve RE bioavailability and synergize with the potential therapeutic action of the extract. Herein, we have investigated the tolerability and safety of the supplement and the biological and molecular effects from an immuno-nutritional perspective. Sixty healthy volunteers participated in a six week, double-blind, randomized parallel pilot study with two study arms: RE-AKG capsules (CR) and control capsules (CC). Mean age (±SD) of volunteers was 28.32 (±11.39) and 27.5 (±9.04) for the control and the study groups, respectively. Safety of the CR product consumption was confirmed by analyzing liver profile, vital constants, and oxidation markers (LDLox in blood and isoprostanes and thromboxanes in urine). The following were monitored: (1) the phenotyping of plasmatic leukocytes and the ex vivo response of lipopolysaccharide (LPS)-stimulated peripheral blood mononuclear cells (PBMCs); (2) expression of genes associated with immune-modulation, inflammation, oxidative stress, lipid metabolism, and tumorigenesis; and (3) the correlation of selected genetic variants (SNPs) with the differential responses among individuals. The lack of adverse effects on liver profile and oxidation markers, together with adequate tolerability and safe immunological adaptations, provide high-quality information for the potential use of CR as co-adjuvant of therapeutic strategies against colorectal cancer.
AuthorsMarta Gómez de Cedrón, José Moises Laparra, Viviana Loria-Kohen, Susana Molina, Juan Moreno-Rubio, Juan Jose Montoya, Carlos Torres, Enrique Casado, Guillermo Reglero, Ana Ramírez de Molina
JournalNutrients (Nutrients) Vol. 11 Issue 9 (Aug 24 2019) ISSN: 2072-6643 [Electronic] Switzerland
PMID31450563 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Fish Oils
  • Plant Extracts
Topics
  • Adolescent
  • Adult
  • Animals
  • Cell Line, Tumor
  • Colorectal Neoplasms (drug therapy, metabolism, pathology)
  • Dietary Supplements (adverse effects)
  • Double-Blind Method
  • Female
  • Fish Oils (administration & dosage, adverse effects, isolation & purification)
  • Healthy Volunteers
  • Humans
  • Leukocytes (drug effects, immunology, metabolism)
  • Liver (chemistry)
  • Male
  • Patient Safety
  • Pilot Projects
  • Plant Extracts (administration & dosage, adverse effects, isolation & purification)
  • Risk Assessment
  • Rosmarinus (chemistry)
  • Sharks
  • Spain
  • Time Factors
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: